Lonza 4D or equal nucleofection system

Description: The U.S. Food and Drug Administration is seeking a Lonza 4D or equal nucleofection system to support ongoing research involving the transfection of various cell lines. The system must support efficient, low-cytotoxicity delivery of DNA, RNA, and proteins across cell types, including human primary cells, and accommodate specified cell-volume and viability requirements. This is an active equipment procurement with firm-fixed-price line items, installation and training requirements, and associated compliance documentation; it is not a grant program.